8-K

                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                              Washington, DC 20549

                                    FORM 8-K

                                 CURRENT REPORT
                        PURSUANT TO SECTION 13 OR 15 (d)
                     OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported):  August 1, 2003

                                    QT 5, INC
               (Exact name of Registrant as specified in charter)


     Delaware                          0-25022                  72-7148906
(State or other jurisdiction   (Commission File Number)       (IRS Employer
of incorporation)                                         Identification Number)

                       5655 Lindero Canyon Road, Suite 120
                       Westlake Village, California 91362
                    (Address of principal executive offices)


Registrant's telephone number, including area code:  (818) 338-1510


                                 Not applicable
          (Former name or former address, if changed since last report)








Item 5.  Other Events and Regulation FD Disclosure.

         Legal Action Against Platinum Products, LLC.

         On August 1, the Registrant issued a press release responding to
allegations made by Platinum Products, LLC and announcing planned legal action
to enforce its exclusive licensing agreement with Marshall Anlauf Thompson. The
full text of the press release is set forth in Exhibit 99.1 attached hereto and
is incorporated in this Report as if fully set forth herein.


Item 7.  Financial Statements and Exhibits

         (a)      Financial Statements of Businesses Acquired. Not applicable.

         (b)      Pro Forma Financial Information Not applicable.

         (c)      Exhibits

                  Exh. No.         Description
                  --------         -----------

                  99.1             Press Release dated August 1, 2003










                                   SIGNATURES

         Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

Date:  August 1, 2003                      QT 5, INC.

                                           By: /s/ Steve Reder
                                              -----------------
                                              Steve Reder
                                              President






                         Exhibits Filed With This Report

Exh. No.          Description
- --------          -----------

99.1              Press Release dated August 1, 2003

EX-99.1

                                                          Exhibit 99.1


[QT 5, Inc. LOGO]                                          August 1, 2003 14 EDT
                                                          FOR IMMEDIATE RELEASE:


 QT 5 Intends to Vigorously Enforce its Licensing Agreement; Plans Legal Action
    Against Platinum Products & Patent Holder to Enforce Licensing Agreement

WESTLAKE VILLAGE, CA -- August 1, 2003 -- QT 5, Inc. (OTC Bulletin Board: QTFV),
manufacturer and marketers of NICOWater(TM), the breakthrough Homeopathic
Nicotinum (nicotine) product designed to relieve the symptoms of tobacco
cravings, announced today, in response to a press release issued by Platinum
Products, LLC, that it intends to file a temporary restraining order to enforce
its exclusive licensing agreement (Licensing Agreement) with Marshall Anlauf
Thompson ("Thompson") regarding US Patent # 6,268,386 ("Patent"). QT 5, Inc. has
already filed an arbitration petition against the patent holder and has not
received any response to date. The Company also announced today that it intends
to file a lawsuit against Platinum Products for tortious interference with
customer relationships.

The Platinum Products press release alleges that it has acquired rights to the
US Patent # 6,268,386, to which QT 5, Inc. currently holds an exclusive license
for marketing and distribution of any products based on this patent. Platinum
Products alleges that Thompson, the Patent holder, has terminated his exclusive
Licensing Agreement with QT 5, Inc. QT 5, Inc. denies any such claim that it has
failed to fulfill any material obligation pursuant to the licensing agreement
and intends to vigorously enforce its manufacturing and distribution rights
pursuant to the Licensing Agreement with Thompson.

"QT 5 has reviewed in detail the allegations set forth in Platinum Products
press release, and we believe their allegations have no merit," said Steve
Reder, QT 5 Inc.'s President. "We intend to defend our rights under our
exclusive Licensing Agreement with Thompson and will file a suit against
Thompson immediately to enforce our agreement. We are confident that we will
prevail in this matter as QT 5 is in full compliance of all of material terms of
the Licensing Agreement. The Company also intends to fulfill its obligations to
its clients and distributors and will continue distributing NICOWater pursuant
to its Licensing Agreement."

About QT 5, Inc.
QT 5, Inc. is a Delaware corporation formed in April 1999 as a manufacturer,
distributor and marketer of Bio-Med testing and Homeopathic products. QT 5, Inc.
is continuing its clinical research and development of future products for
lifestyle enhancements. QT 5, Inc. is headquartered in Westlake Village,
California. For more information please visit: www.qt5inc.com. NICOWater(TM)is a
Homeopathic Drug product that is sold under the FDA's Compliance Policy Guide
Conditions Under Which Homeopathic Drugs May Be Marketed.

Cautionary Statement
This release contains forward-looking statements that involve risks and
uncertainties, such as statements about our plans, objectives, expectations,
assumptions or future events. These statements involve estimates, assumptions,



known and unknown risks, uncertainties and performances, or achievements
expressed or implied by the forward-looking statement. Actual future results and
trends may differ materially from those made in or suggested by any
forward-looking statements due to a variety of factors, including, for example,
our ability to compete with other products in our space; the risk of unfavorable
federal regulation; and the fact that our status as a development stage company
makes our future unclear. Consequently you should not place undue reliance on
these forward-looking statements. We discuss many of these and other risks and
uncertainties in greater detail under the section entitled, "Risk Factors That
May Affect Future Results" in Item 1 of the Company's Current Report on Form 8-K
as filed with SEC on January 24, 2003 (the "Merger Form 8-K").


Contact:
Steven Reder
President
QT 5, Inc.
818-338-1510